Psychopharmacologic treatment of generalized anxiety disorder and the risk of major depression

American Journal of Psychiatry

Volumn 159, Issue 11, 2002, Pages 1935-1937

  Goodwin, Renée D ^a   Gorman, Jack M ^a  

^a Unit 43 ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PSYCHOTROPIC AGENT;

ADOLESCENT; ADULT; ANXIETY DISORDER; ARTICLE; COMORBIDITY; CONTROLLED STUDY; DRUG USE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; PRIORITY JOURNAL; PSYCHOPHARMACOLOGY; RISK ASSESSMENT; RISK FACTOR;

ADOLESCENT; ADULT; ANTI-ANXIETY AGENTS; ANXIETY DISORDERS; COMORBIDITY; DEPRESSIVE DISORDER, MAJOR; FEMALE; HUMANS; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; RISK;

EID: 0036843810     PISSN: 0002953X     EISSN: None     Source Type: Journal    
DOI: 10.1176/appi.ajp.159.11.1935     Document Type: Article

References (22)

1. Judd LL, Kessler RC, Paulus MP, Zeller PV, Wittchen HU, Kunovac JL: Comorbidity as a fundamental feature of generalized anxiety disorders: Results from the National Comorbidity Study (NCS). Acta Psychiatr Scand Suppl 1998; 393:6-11
2. Parker G, Wilhelm K, Asghari A: Early onset depression: The relevance of anxiety. Soc Psychiatry Psychiatr Epidemiol 1997; 32: 30-37
3. Kendler KS, Neale MC, Kessler RC, Heath AC, Eaves LJ: Major depression and generalized anxiety disorder: Same genes, (partly) different environments? Arch Gen Psychiatry 1992; 49:716-722
4. Kessler RC, DuPont RL, Berglund P, Wittchen HU: Impairment in pure and comorbid generalized anxiety disorder and major depression at 12 months in two national surveys. Am J Psychiatry 1999; 156:1915-1923
5. Kessler RC, Keller MB, Wittchen HU: The epidemiology of generalized anxiety disorder. Psychiatr Clin North Am 2001; 24:19-39
6. Wittchen HU, Carter RM, Pfister H, Montgomery SA, Kessler RC: Disabilities and quality of life in pure and comorbid generalized anxiety disorder and major depression in a national survey. Int Clin Psychopharmacol 2000; 15:319-328
7. Levine J, Cole DP, Chengappa KN, Gershon S: Anxiety disorders and major depression, together or apart. Depress Anxiety 2001; 14:94-104
8. Wittchen HU, Kessler RC, Pfister H, Lieb M: Why do people with anxiety disorders become depressed?a prospective-longitudinal community study. Acta Psychiatr Scand Suppl 2000; 406:14-23
9. Regier DA, Rae DS, Narrow WE, Kaelber CT, Schatzberg AF: Prevalence of anxiety disorders and their comorbidity with mood and addictive disorders. Br J Psychiatry Suppl 1998; 34:24-28
10. Andrade L, Eaton WW, Chilcoat HD: Lifetime comorbidity of panic attacks and major depression in a population-based study: Age of onset. Psychol Med 1996; 26:991-996
11. Kessler RC, McGonagle KA, Zhao S, Nelson CB, Hughes M, Eshleman S, Wittchen HU, Kendler KS: Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States: Results from the National Comorbidity Survey. Arch Gen Psychiatry 1994; 51:8-19
12. Kessler RC, Little RJA, Groves RM: Advances in strategies for minimizing and adjusting for survey nonresponse. Epidemiol Rev 1995; 17:192-204
13. World Health Organization: Composite International Diagnostic Interview (CIDI), Version 1.0. Geneva, WHO, 1990
14. Wittchen HU: Reliability and validity studies of the WHO Composite International Diagnostic Interview (CIDI): A critical review. J Psychiatr Res 1994; 28:57-84
15. Wittchen HU, Kessler RC, Zhao S, Abelson J: Reliability and clinical validity of UM-CIDI DSM-III-R generalized anxiety disorder. J Psychiatry Res 1995; 29:95-110
16. Goodwin R, Olfson M: Treatment of panic attack and risk of major depressive disorder in the community. Am J Psychiatry 2001; 158:1146-1148
17. Ninan PT: Recent perspectives on the diagnosis and treatment of generalized anxiety disorder. Am J Manag Care 2001; 7: S367-S376
18. Trivedi MH, Rush AJ, Carmody TJ, Donahue RM, Bolden-Watson C, Houser TL, Metz A: Do bupropion SR and sertraline differ in their effects on anxiety in depressed patients? J Clin Psychiatry 2001; 62:776-781
19. Carter RM, Wittchen HU, Pfister H, Kessler RC: One-year prevalence of subthreshold and threshold DSM-IV generalized anxiety disorder in a nationally representative sample. Depress Anxiety 2001; 13:78-88
20. Katzelnick DJ, Kobak KA, DeLeire T, Henk HJ, Greist JH, Davidson JRT, Schneier FR, Stein MB, Helstad CP: Impact of generalized social anxiety disorder in managed care. Am J Psychiatry 2001; 158:1999-2007
21. Jones GN, Ames SC, Jeffries SK, Scarinci IC, Brantley PJ: Utilization of medical services and quality of life among low-income patients with generalized anxiety disorder attending primary care clinics. Int J Psychiatry Med 2001; 31:183-198
22. Murray CJ, Lopez AD: Alternative projections of mortality and disability by cause 1990-2020: Global burden of disease study. Lancet 1997; 349:1498-1504